Sustained expression of murine interferon (IFN)-g (Mug) was found to be effective in preventing tumor metastasis and atopic dermatitis in mouse models. However, our preliminary experiments suggested that the time-dependent decrease in the Mug expression was not compensated for by repeated injections of Mug-expressing plasmid. To identify the mechanism underlying this observation, a reporter plasmid was hydrodynamically injected into mice and the levels of the plasmid, mRNA and reporter protein were measured in mice receiving a pre-or co-administration of Mug-expressing plasmid. Co-injection of Mug-expressing plasmid had no significant effects on transgene expression from the reporter plasmid. In contrast, pre-injection of Mugexpressing plasmid greatly inhibited the expression of the reporter protein. Moreover, pre-injection of Mug-expressing plasmid also reduced the amount of the reporter plasmid in the nuclear fraction of mouse liver to o10%, and that of reporter mRNA to o1%. The degree of reduction in the expression of reporter protein was comparable with the reduction in mRNA. These results indicate that the difficulty in regaining the expression level of IFN-g is due to the impaired delivery of plasmid to the nucleus and to the suppression of transcription from the plasmid.
INTRODUCTION
Interferon (IFN) is a cytokine with diverse biological activities, including antiviral, antiproliferative and immunomodulatory effects. Both type I (IFN-a, b) and type II (IFN-g) IFNs are used in patients to treat diseases, such as cancer, viral infections and allergic disorders. [1] [2] [3] [4] [5] In general, IFNs are quickly degraded and eliminated in biological environments, so that their therapeutic effects are not long-lasting enough to successfully exert their therapeutic benefits when administered as therapeutic agents. It has been proven that PEGylation could reduce the high clearance of human IFN-a or IFN-b, and improve its therapeutic effects. 6, 7 This indicates that the therapeutic effects of IFNs can be enhanced by increasing their retention time in the systemic circulation.
Gene delivery, in which a therapeutic protein is expressed from administered DNA vector, is a promising approach to prolong the retention time of IFNs in the systemic circulation. In fact, IFN gene therapy has been applied to the treatment of a variety of tumors. [8] [9] [10] To achieve long-term expression of IFN-g, we developed plasmid vectors that express murine IFN-g (Mug) for a long period of time. 11, 12 A single administration of the newly constructed IFN-gexpressing plasmids by the hydrodynamic injection method, which is a most efficient method for in vivo gene transfer, 13 was effective in obtaining therapeutic levels of IFN-g over 480 days and in exerting marked therapeutic effects in various diseases models, including metastatic tumor and atopic dermatitis. 11, 12, 14 In these studies, transient expression of IFN-g showed little therapeutic effect, emphasizing the importance of sustained expression.
A further increase in the duration of the therapeutic effect would be expected by repeated gene transfer. In a preliminary experiment, we found that transgene expression from the subsequently delivered plasmid vector by the hydrodynamic injection method is markedly suppressed in mice that were transfected with Mug-expressing plasmid DNA. To understand the mechanism underlying this suppression, the effects of IFN-g on the transgene expression from plasmid DNA were evaluated by measuring the amounts of proteins expressed from the plasmid DNA as well as the amounts of plasmid DNA in the nucleus and the amounts of transgene mRNA. Figure 1a shows the time course of the Mug concentration in mouse serum after repeated hydrodynamic injections of 0.1 mg pCpG-Mug. In accordance with our previous report, 12 a single injection of pCpGMug resulted in a high and sustained Mug concentration in the serum. However, a second injection of pCpG-Mug on day 7 only slightly increased the concentration of Mug. The serum concentration of Mug after the second injection of pCpG-Mug was much lower than that in mice receiving a first hydrodynamic injection of pCpG-Mug at 7 days, and was comparable with that after the hydrodynamic injection of pcDNA3.1 on day 7. The plasmid-independent increase in the concentration of Mug could be due to the reactivation of silenced transgene expression induced by hydrodynamic injection. 15 To confirm whether the biological activity of Mug is responsible for the reduced expression from the secondary injected plasmid, pEF1-Hug, a plasmid expressing human IFN-g (Hug) that has no biological activities in mice, was first injected, followed by an injection of pCpGMug. This resulted in significantly high levels of serum Mug compared with repeated injections of pCpG-Mug. These results indicate that transgene expression from pCpG-Mug injected for a second time was almost completely suppressed because of the biological activity of Mug.
RESULTS

Time course of IFN-c concentration in serum after repeated injection of plasmid DNA
To further confirm whether the suppression is mediated by the biological activity of Mug, pEF1-Hug was injected into mice twice with a 1-week interval between the injections. The second injection of pEF1-Hug on day 7 increased the serum level of Hug to a level comparable with that obtained after the first injection (Figure 1b) . Thus, it is reasonable to conclude that the suppressed expression after repeated injections of pCpG-Mug is due to the biological activities of Mug.
Because liver cells are the major cells responsible for transgene expression after hydrodynamic injection, the reduced expression following repeated injection of Mug-expressing plasmids could be related to changes induced by Mug expressed in those cells. To test this hypothesis, mice first received an intramuscular injection of Mug-expressing plasmid, followed by a hydrodynamic injection of pCpG-Mug 7 days after the intramuscular injection. An intramuscular injection of pCpG-Mug resulted in moderate concentrations of Mug in the serum (Figure 1c ). The serum concentrations of Mug after hydrodynamic injection of pCpG-Mug in mice that had received an intramuscular injection of Mug was much lower than that in mice that had received an intramuscular injection of pcDNA3.1, a mock vector. These results strongly suggest that transgene expression in mouse liver is markedly inhibited when the serum concentration of Mug is high.
Effect of Muc gene transfer on transgene expression of luciferase
To quantitatively evaluate the inhibitory effects of Mug on transgene expression, pCMV-Luc, a plasmid expressing firefly luciferase, was employed and luciferase activity in the liver was measured for quantitative evaluation. First, the effect of the timing of the Mugexpressing plasmid injection on luciferase gene expression from pCMV-Luc was investigated. When mice received an injection of pCMV-Luc together with pCpG-Mug, a plasmid that provides sustained expression of Mug, the luciferase activity in the liver was slightly, but not significantly, less than that in mice receiving a co-injection of pCMV-Luc and pcDNA3.1 (Figure 2a) . However, an injection of pCpG-Mug 2 or 7 days before the pCMV-Luc injection markedly reduced the luciferase expression by 23-or 202-fold, respectively, compared with the pcDNA3.1-injected group. When pCMV-Mug, a plasmid that transiently expresses Mug, was used instead of pCpG-Mug, the luciferase activity was significantly inhibited only when this plasmid was injected 2 days before injection of pCMV-Luc. Because the serum level of Mug after injection of pCMVMug was transient compared with that after pCpG-Mug injection and there was no detectable Mug in the serum at 7 days after hydrodynamic injection of pCMV-Mug, 12 the different suppressive effects of the two Mug-expressing plasmids are due to the difference in the serum concentration of Mug.
Next, mice received an intramuscular injection of either pGpG-Mug or pcDNA3.1 followed by electroporation, and a hydrodynamic injection of pCMV-Luc after an interval of 7 days. As shown in Figure 2b , the luciferase expression in the liver of the pCpG-Mug-injected mice was less than one tenth that in the pcDNA3.1-injected group.
Effect of Muc on the transgene expression processes after hydrodynamic injection of plasmid DNA There are several processes in the transgene expression from plasmid DNA: the delivery of DNA to the nucleus, mRNA synthesis from the DNA (transcription) and protein synthesis from the mRNA (translation). To understand which processes are inhibited by Mug, 
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Hug-expressing plasmid pCMV-Hug was selected as a reporter plasmid and was delivered by hydrodynamic injection simultaneously or 7 days after hydrodynamic injection of pCpG-Mug or an empty plasmid pCpG-mcs. Then, the amounts of intranuclear pCMV-Hug and Hug mRNA in liver, and Hug protein in serum were measured. Figure 3a shows the time courses of the amounts of intranuclear pCMV-Hug in the liver of mice that had received a pre-injection of pCpG-Mug or pCpG-mcs. Although the injection of pCpG-mcs hardly affected the amount of intranuclear pCMV-Hug compared with the untreated group, injection of pCpG-Mug significantly reduced the amount of pCMV-Hug at all time points examined. Figure 3b shows the total amount of pCMV-Hug in the liver at 2 h after injection. Again, the amount in the pCpG-Mug-injected group was significantly lower than that in the other groups. The differences between the pCpG-mcs-and the pCpG-Mug-injected groups were about 38-and 18-fold for the amounts in the liver and nucleus, respectively. Therefore, it appears that the intracellular/intranuclear delivery of subsequently injected plasmid DNA is markedly inhibited under conditions where the concentration of Mug is high. In all cases examined, the level in the nucleus was almost constant from 10 min to 24 h after injection (Figure 3a) . Therefore, the time point of 24 h was selected to evaluate the level of intranuclear DNA in the following experiments. Figure 3c shows the amounts of intranuclear DNA in mouse liver after hydrodynamic injection of pCMV-Hug, pEF1-Hug or pROSAHug. Co-injection of pCpG-Mug hardly affected the amount of intranuclear pCMV-Hug compared with the amount after the single injection of pCMV-Hug or co-injection of pCpG-mcs. Mice receiving a pre-injection of pCpG-Mug had a significantly lower level of intranuclear pCMV-Hug compared with those untreated or injected with pCpG-mcs; o10% was detected in the nucleus. Expression of Mug in skeletal muscle was also effective in reducing the amount of pCMV-Hug in the nucleus of mouse liver, suggesting that the type of cell expressing Mug is not important for this Mug-mediated inhibition of nuclear delivery of DNA in the liver. Next, to examine the effects of specific properties of plasmid DNA, such as promoter and enhancer, on nuclear delivery, pCMV-Hug was replaced with pROSA-Hug or pEF1-Hug. Even although the levels of reduction varied from 89.5 to 98.0%, pre-injection of pCpG-Mug significantly reduced the nuclear delivery of subsequently injected plasmid DNA irrespective of its type (Figure 3c ).
Then, the relative level of Hug mRNA in mouse liver was measured (Figure 3d) . Again, the levels of Hug mRNA were significantly lower in mice receiving Mug-expressing plasmid. Finally, Hug expression was evaluated by measuring the serum concentration of Hug at 24 h after injection (Figure 3e) . The results were comparable with those of the mRNA expression (Figure 3d) .
To compare the Mug-mediated suppression in the processes of transcription (DNA to mRNA) and translation (mRNA to protein), the ratios of the relative levels of mRNA to DNA and protein to mRNA were calculated, and the percentages to those of the no treatment group were shown in Figures 3f and g, respectively. The mRNA/nDNA ratios in the Mug pre-treated groups were o10% of that in the control group. On the other hand, the protein/mRNA ratios in the Mug pre-treated groups were nearly 100% of that in the control group. These results clearly indicate that, irrespective of the method of injection of pCpG-Mug or the type of reporter plasmids, the transcription process was markedly suppressed by Mug gene transfer, whereas the translation process was not.
Effect of Muc on transgene expression in cultured C2C12 cells
Finally, the effects of Mug on transgene expression in cultured cells were examined using C2C12 cells, a murine myoblast cell line. C2C12 cells were first incubated with different concentrations (1-1000 U ml À1 ) of Mug for 24 h, then transfected with pCpG-Luc, a plasmid expressing firefly luciferase. Figure 4 shows the luciferase activity in cells at 28 h after transfection. The pre-treatment of cells with Mug at concentrations of 100 U ml À1 or higher significantly reduced the luciferase activity.
DISCUSSION
Suppression of transgene expression from plasmid or viral vectors was observed under a variety of experimental conditions where transgenes were driven by widely used viral promoters/enhancers, such as cytomegarovirus, simian virus 40 and Rous sarcoma virus. [16] [17] [18] [19] [20] [21] [22] [23] Although the mechanisms underlying these suppressive events have not fully been elucidated and would depend on the type of vectors and/or promoters, it is suggested that cytokines, including tumor necrosis factor (TNF)-a and IFN-g, are involved in the suppression. 20, 24, 25 Such cytokines are induced as a biological response to viral and non-viral vectors, including plasmid DNA/cationic liposome complexes or lipoplex. 26 Because the lipoplex-induced cytokine production is dependent on the presence of unmethylated CG dinucleotides (CpG motifs) in plasmid DNA, 27 reduction or depletion of CpG motifs from plasmid vectors markedly reduced the production of these pro-inflammatory cytokines. 28 Furthermore, the reduction in the number of CpG motifs was linked with the prolonged transgene expression from the vectors delivered by hydrodynamic injection, suggesting that CpG-depleted plasmid vectors are useful for sustained transgene expression. 11, 12 Even though this conclusion seems to be valid in terms of safety or reduced cytokine production, especially when lipoplex is used for transfection, 29 our previous study rejected the hypothesis that pro-inflammatory cytokines inhibit transgene expression from plasmid vectors. 12 In our previous study, 10 the lipoplex-induced pro-inflammatory cytokines, such as tumor necrosis factor-a, IFN-g and interleukin-12, did not reduce transgene expression from plasmid vectors. 
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The finding that the expression of Mug from pCpG-Mug was markedly suppressed in mice that had previously received the same plasmid (Figure 1 ) does not agree with the results of the previous studies, in which transgene expression was hardly affected by proinflammatory cytokines, including IFN-g. This discrepancy could be explained by the difference in the profiles of IFN-g and other cytokines between the previous and present studies; for example, lipoplex-induced cytokine production is transient, whereas the expression of Mug from pCpG-Mug is sustained. This hypothesis is supported by the experimental results of pCMV-Mug, a short-term expressing plasmid. No significant inhibition in transgene (luciferase) expression was observed when pCMV-Luc was injected 7 days after Mug gene transfer (Figure 2a) . Therefore, these results suggest that the long-term expression of IFN-g is important for the IFN-g-mediated suppression of transgene expression. Transgene expression in cultured C2C12 cells were also markedly inhibited by Mug (Figure 4) , although the reduced level was much less than that after in vivo gene transfer. However, attention should be paid to the differences in the experimental conditions between the in vivo gene transfer to mouse liver and the cationic liposome-mediated transfection to cultured cells.
As IFN-g is an antiviral agent, its suppressive effects on gene expression have been extensively studied. It has been reported that IFN-g induced cellular proteins, such as Stat-1, which could result in reduced expression of transgene. 17, 30, 31 Another study raised the possibility that IFN-g decreases the stability of several transcripts, including c-myc, c-fos and cftr. 18 However, such events would not be involved in the Mug-mediated suppression of transgene expression in the present study, because a single hydrodynamic injection of pCpGMug results in a sustained level of Mug in mouse serum, indicating that the transgene expression from pCpG-Mug is not suppressed by Mug. 12, 14 Furthermore, post-(data not shown) or co-injection of pCpG-Mug had no significant effects on the expression from plasmids encoding reporter proteins. Therefore, the induction or activation of cellular proteins, such as Stat-1, would not be involved in the IFN-gmediated suppression of transgene expression.
A quantitative analysis of plasmid DNA demonstrated that the delivery of DNA to the cells of liver (Figure 3b ) and the nucleus of liver cells (Figure 3c ) is markedly reduced by Mug to similar levels. It seems reasonable to speculate that the inhibitory effect of Mug on the plasmid delivery to the nucleus is due to the reduced delivery of the DNA to the liver. However, the amount of plasmid DNA in the nucleus was only about 1% of that in the whole liver. Therefore, it is hard to conclude that the lower delivery of plasmid DNA to the liver is the sole mechanism of the lower amount of the DNA in the nucleus, because other reasons than the amount of plasmid DNA in the whole liver may be responsible for the reduced delivery of plasmid DNA to the nucleus. It has been suggested that intracellular delivery of plasmid DNA by hydrodynamic injection is through cell membranes with a high permeability. 32, 33 After entering the cytosol, plasmid DNA was reported to enter the nucleus depending on the specific sequences of DNA. 34 In the present study, we did not observe any significant differences in the intranuclear amounts of DNA among the plasmids with different sequences (Figure 3) . Because it is not completely proven how plasmid DNA is delivered to the cytosol and to the nucleus in the liver after hydrodynamic injection, the precise mechanism of IFN-g-mediated suppression needs further study.
Another important finding of the present study is that the mRNA expression from plasmid DNA in the nucleus is also inhibited by IFN-g (Figures 3d and f) . Based on the amounts of plasmid DNA in the nucleus and mRNA, the efficiency of mRNA expression can be estimated to be 100% (control), and 4.6% (pCpG-Mug pre-administered by hydrodynamic injection) for pCMV-Hug. These results indicate that the transcription process is also inhibited by Mug under these conditions. However, it is interesting to note that the efficiency of mRNA expression of the pCpG-Mug co-injection group was not different from that of the control group. Little effect of Mug on transgene expression was also observed when pCpG-Mug was injected to mice that had been injected with a reporter plasmid (data not shown). Taken together, it seems that Mug hardly affects the transcription from pre-existing plasmids. It is known that transcription from plasmid DNA requires the recruitment of various proteins, including TATA-binding protein, TATA-binding protein-associated factors, transcription factor IIA and so on. 35 It has been reported that INF-g suppresses the transcription of pro-inflammatory mediator-induced cyclooxygenase-2 by selectively inhibiting the binding activity of c-Jun and CCAAT/enhancer binding protein b to DNA and p300 recruitment in human cells. 36 In another literature, it was reported that IFN-g regulates tumor necrosis factor-a-induced transcription, and prolonged IFN-g treatment potentiates the capacity of tumor necrosis factor-a to induce nuclear Stat-1 DNA binding. 37 Based on these experimental results, it can be speculated that Mug interferes with the interaction of proteins that are indispensable for the expression of transgenes to the corresponding DNA sequences, which also occurs in the case of other cytokines, such as interleukin-13. 38 In the cases of post-and co-injection of the Mug-expressing plasmid, the proteins responsible for transgene expression should have bound to the reporter plasmids, because transcription has already started before the presence of Mug. The absence of significant effects of Mug on pre-expressing plasmid DNA suggests that it is difficult for Mug to disturb the interaction of DNA and proteins, as well as the following processes, including transcription. Taken together, one possible mechanism in the present study may be that Mug change the association of transcription factors to plasmid vectors.
In conclusion, IFN-g inhibits the nuclear delivery of plasmid DNA and transcription, both of which are causes for the failure of repeated gene transfer of IFN-g. Cells not exposed to IFN-g should be selected as target cells for gene transfer if repeated IFN-g gene transfer is needed.
MATERIALS AND METHODS Mice
Four-week-old male ICR mice, B20 g in weight, were purchased from Japan SLC, Inc. (Hamamatsu, Japan) and were maintained under conventional housing conditions. The protocols for animal experiments were approved by Plasmid DNA pcDNA3.1 was purchased from Invitrogen (Carlsbad, CA, USA). pCpG-mcs, which contains no CpG motifs, was obtained from Invivogene (San Diego, CA, USA). Mug-expressing plasmid vectors (pCMV-Mug and pCpG-Mug) and luciferase-expressing plasmid vectors (pCMV-Luc and pCpG-Luc) were constructed as previously reported. 12,39 pEF1-Hug was constructed by inserting the BglII/NheI Hug cDNA fragment amplified by PCR into the BglII/NheI site of pCpG-mcs. pEF1-Hug was digested by SdaI, then the product which contains the part of Hug cDNA was treated with T4 polymerase blunting the ends to the NruI recognition site. Then, the product was digested by HindIII to obtain the fragment with the NruI/HindIII site. The fragment from pEF1-Hug with the NruI/HindIII site was ligated with the NruI/HindIII cytomegarovirus promoter fragment from pCMV-Luc to obtain pCMV-Hug. pROSA-Hug was constructed by inserting the SdaI/HindIII ROSA promoter fragment from pBROAD2-mcs (Invivogene) into the SdaI/HindIII site of pEF1-Hug. The plasmids used in this study are summarized in Table 1 .
In vivo gene transfer
For gene transfer to the liver, mice received a tail vein injection of plasmid DNA dissolved in a large volume of saline (8% volume of body weight) over 5 s. 13 In a separate group of mice, gene transfer to skeletal muscle was performed by an injection of plasmid DNA into the gastrocnemius muscle, followed by electroporation (200 V cm À1 , 5 ms per pulse, 12 pulses, 4 Hz) 40 using a pair of 1-cm 2 forceps-type electrodes connected to a rectangular direct current generator (CUY-21, Nepagene, Chiba, Japan).
Measurement of serum concentrations of Muc and Huc
At indicated periods after gene transfer, 50-200 ml blood was collected from the tail vein. The blood samples were incubated at 4 1C for 2 h to allow clotting and then centrifuged at 8000 g to obtain serum. The concentration of Mug and Hug in the serum was analyzed by ELISA using commercial kits (Ready-SET-Go! Mouse IFN-g ELISA and Ready-SET-Go! Human IFN-g ELISA, eBioscience, San Diego, CA, USA).
Luciferase assay
At indicated periods after injection, mice were killed and the liver was harvested and homogenized in 5 ml g À1 lysis buffer (0.1 M Tris, 0.05% Triton X-100, 2 mM EDTA, pH 7.8). The homogenates were centrifuged at 10 000 g for 10 min at 4 1C. Then, 5 ml of the supernatant was mixed with 50 ml luciferase assay buffer (Picagene, Tokyo Ink, Tokyo, Japan) and the chemiluminescence was measured in a luminometer (Lumat LB 9507, EG&G Bethhold, Bad Wildbad, Germany).
Isolation of nuclear DNA
Mice were killed at indicated time points and the liver was harvested and homogenized in 2.5 ml g À1 PBS. Then, the sample was centrifuged at 2500 g for 5 min at 4 1C. After the pellet was washed three times with PBS, it was resuspended in 0.5 ml lysis buffer (0.5% Nonidet P-40, 10 mM Tris-HCl, 10 mM NaCl, 3 mM MgCl 2 , pH 7.4) to dissolve the plasma membrane.
The nuclear fraction was isolated by centrifugation at 1400 g for 5 min at 4 1C. The pellet was washed twice with the lysis buffer, and the final pellet was used as the nuclear fraction. 41, 42 The intranuclear DNA was extracted using a DNeasy Blood & Tissue Kit (QIAGEN GmbH, Hilden, Germany). Total concentrations of DNA were determined by measurement of the absorbance at 260 nm in a UV-1600 spectrophotometer (Shimadzu, Kyoto, Japan).
Isolation of mRNA
Total RNA was extracted from B100 mg liver using Sepasol RNA I Super (Nacalai Tesque, Kyoto, Japan). Following RNase-free DNase I treatment (Takara, Tokyo, Japan), reverse transcription was performed using a SuperScript II (Invitrogen) and oligo(dT) primer according to the manufacturer's protocol to obtain total cDNA.
Quantitative real-time PCR of intranuclear DNA and mRNA Real-time PCR was carried out using intranuclear DNA, total DNA or total cDNA on a Light-Cycler instrument (Roche Diagnostics, Basle, Switzerland). The oligodeoxynucleotide primers used for amplification were as follows: Hug forward, 5¢-TGACCAGAGCATCCAAAAGA-3¢, reverse, 5¢-CTCTTCGACCT CGAAACAGC-3¢; GAPDH forward, 5¢-ACGGATTTGGTCGTATTGGG-3¢, reverse, 5¢-CGCTCCTGGAAGATGGTGAT-3¢. Amplification products were detected online via intercalation of the fluorescent dye SYBR green (LightCycler-FastStart DNA Master SYBR Green I kit, Roche Diagnostics). The cycling conditions were as follows: initial enzyme activation at 95 1C for 10 min, followed by 55 cycles at 95 1C for 10 s, 58 1C for 5 s and 72 1C for 15 s for Hug. The cycling conditions for GAPDH were the same as those for Hug except that the annealing temperature was 56 1C. All cycling reactions were performed in the presence of 3.5 mM MgCl 2 . Gene-specific fluorescence was measured at 72 1C. The mRNA expression of target genes was normalized using the mRNA level of GAPDH. The level of intranuclear Hug DNA was normalized by the total DNA concentration of the sample.
Cell culture and transfection
C2C12 cells were obtained from RIKEN BioResource Center (Ibaraki, Japan) and cultured in Dulbecco's modified Eagle medium (Nissui Co. Ltd, Tokyo, Japan) supplemented with 10% heat-inactive fetal bovine serum. C2C12 cells plated on 12-well culture plates (at a density of 1Â10 5 cells per well) were incubated with different concentrations of Mug for 24 h. Then, the cells were transfected with pCpG-Luc using Lipofectamine 2000 (Invitrogen) at a final concentration of 1 mg DNA per well according to the manufacturer's instructions. In brief, 1 mg of plasmid DNA was mixed with 3 ml Lipofectamine 2000, and the resulting complex was added to the cells. Cells were incubated with the complex for 4 h and replaced with the culture medium. The luciferase activity in cells was measured at 24 h after culture medium change.
Statistical analysis
Differences were statistically evaluated by one-way analysis of variance followed by the Tukey's test. The level of statistical significance was set at Po0.05. Inhibition of transgene expression by IFN-c L Zang et al
